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Background: Hybrid liposomes can be prepared by simply sonicating a mixture of vesicular 
and micellar molecules in buffer solutions. In this study, we investigated the effects of hybrid 
liposomes on the growth of human colon cancer cells in vitro.
Methods: Hybrid liposomes (HL-n, n = 21, 23, 25) composed of L-α-dimyristoylphosphatidyl-
choline (DMPC) and polyoxyethylene(n) dodecyl ethers (C12(EO)n, n = 21, 23, 25) were 
  prepared by the sonication method and their inhibitory effects on growth of human colon cancer 
HCT116 cells were examined in vitro.
Results: Significant growth inhibition of HCT116 cells was observed in the presence of HL-n. 
The fifty percent inhibitory concentration (IC50) of HL-n was less than half that of DMPC 
liposomes. Furthermore, fluorescence microscopic and flow cytometric analyses indicated that 
the markedly inhibitory effects of HL-n on the growth of HCT116 cells could be attained through 
the induction of cell cycle arrest at the G0/G1 phase along with apoptotic cell death.
Conclusion: It was found for the first time that HL-n can induce both cell cycle arrest and 
apoptosis in colon cancer cells. The findings in this study should contribute to novel chemo-
therapy for colon cancer.
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Introduction
Colorectal cancer is one of the most malignant neoplasms in the world and develops 
in the cecum, colon and rectum.1 Generally, patients with tumoral tissues confined 
within the intestinal wall are curable by enucleation of the local lesions. However, 
when the tumors are enlarged and advanced into the deeper regions, it is difficult to 
cure cases with surgical treatment.2 Although chemotherapy with anticancer drugs, 
such as 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin, can prolong survival, 
this therapy may not effect a complete cure for the metastatic carcinoma.2,3 Therefore, 
a new remedy for cancer is urgently needed.
Hybrid liposomes, first developed by Ueoka et al,4 can be prepared by simply 
sonicating a mixture of vesicular and micellar molecules in buffer solutions. Inhibitory 
effects of hybrid liposomes composed of L-α-dimyristoylphosphatidylcholine (DMPC) 
and polyoxyethylene(20) sorbitan monolaurate (Tween 20) including antitumor drugs 
such as 1,3-bis(2-chloroethyl)-1-nitrosourea on the growth of glioma cells in vitro and in 
vivo have been observed.5 On the other hand, hybrid liposomes composed of DMPC and 
polyoxyethylene(n) alkyl ethers without any drugs demonstrated remarkable inhibitory 
effects on the growth of various tumor cells in vitro6–8 and in vivo.9–12 In addition, it has been International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1914
Komizu et al
demonstrated that hybrid liposomes could induce apoptotic cell 
death in leukemia,13 hepatoma,7 lung cancer,14 breast cancer,8 
and primary effusion lymphoma cells.15 With respect to colon 
cancer cell lines, hybrid liposomes induced apoptosis in human 
colon adenocarcinoma WiDr16 and mouse colon carcinoma 
Colon26 cells in vitro.17 Furthermore, we also reported that hybrid 
liposomes distinguished between normal colon CCD33Co cells 
and tumor colon WiDr cells, then fused and accumulated into the 
plasma membranes of tumor cells, leading to apoptosis. More 
recently, it was observed that hybrid liposomes could inhibit 
growth of cholangiocarcinoma cells through induction of cell 
cycle arrest.18 However, research concerning the effects of hybrid 
liposomes on the cell cycle of cancer cells is very limited.
In this study, we investigated the effects of hybrid 
liposomes (HL-n, n = 21, 23, 25) composed of DMPC and 
polyoxyethylene(n) dodecyl ethers (C12(EO)n, n = 21, 23, 
25) on the growth of human colon cancer (HCT116) cells 
in vitro, and found significant inhibitory effects on growth 
of HCT116 cells through induction of cell cycle arrest at the 
G0/G1 phase along with apoptotic cell death.
Materials and methods
Preparation of hybrid liposomes
Hybrid liposomes (HL-n, n = 21, 23, 25) were prepared by 
the following methods.14 DMPC (NOF, Tokyo, Japan) and 
polyoxyethylene(n) dodecyl ethers (C12(EO)n, n = 21, 23, 25) 
(C12(EO)21 and C12(EO)25; Nikko Chemicals, Tokyo, Japan, 
C12(EO)23; Sigma Chemicals, St Louis, MO) were mixed in 
5% glucose solution and sonicated with a bath type sonica-
tor (VS-N300, Velvo-Clear, Tokyo, Japan) at 45°C under a 
nitrogen atmosphere with 300 W, followed by filtration with 
a 0.20 µm filter. The liposomes composed of DMPC were 
prepared in the same manner as described above.
Dynamic light scattering method
The size of the HL-n was measured with an electrophoretic 
light scattering spectrophotometer (ELS-8000, Otsuka 
Electronics, Hirakata, Japan).13 Using a He-Ne laser 
as the light source, a 633 nm laser line with 10 mW 
power was applied with a scattering angle of 90°. The 
hydrodynamic diameter (dhy) of the HL-n was calculated by 
the Stokes-Einstein equation (dhy = kT/(3πηD), where k is 
Boltzmann’s constant, T is the absolute temperature, η is the 
viscosity of solvent, and D is the diffusion coefficient).
Cell culture
Human colon cancer HCT116 cell lines were purchased from 
the American Type Culture Collection (Manassas, VA). 
HCT116 cells were maintained in RPMI-1640 medium 
(Gibco, Gaithersburg, MD) supplemented with penicillin 
100 U/mL, streptomycin 50 µg/mL, and 10% fetal bovine 
serum (HyClone Laboratories, Logan, UT). The cells were 
cultured in a 5% CO2 humidified incubator at 37°C.
WST-1 assay
The inhibitory effects of HL-n on the growth of HCT116 cells 
were examined on the basis of a WST-1 (2-methoxy-4-nitrop-
henyl-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, 
monosodium salt) assay.12 HCT116 cells were seeded at a density 
of 2.0 × 103 cells per well in 96-well plates (Sumitomo Bakelite, 
Tokyo, Japan) and incubated in a humidified atmosphere of 5% 
CO2 at 37°C. After 24 hours, HL-n were added into each well and 
the plates were incubated for 48 hours. The viable cell number 
was measured with a Cell Counting Kit (Dojindo Laboratories, 
Kumamoto, Japan) according to the manufacturer’s instructions, 
and the IC50 of HL-n was determined from the concentration-
dependence of the viable cell number.
Annexin-V labeling assay
Phosphatidylserines exposed on the outer plasma membranes 
of apoptotic HCT116 cells were detected by Annexin-V 
labeling assay.19 HCT116 cells were seeded at a density of 
4.0 × 103 cells in glass bottom dishes (Mat Tek, Flint, MI) in 
a humidified atmosphere of 5% CO2 at 37°C. After 24 hours, 
HL-n were added at the IC50 values and the dishes were 
incubated for 3 hours. Subsequently, the cells were washed 
with phosphate-buffered saline and dyed with an Annexin-V-
FLUOS staining kit (Roche Diagnostics, Basel, Switzerland). 
Briefly, the cells were treated with 2 µL of FLUOS-conjugated 
Annexin-V and 2 µL of propidium iodide stock solutions. 
After incubation for 10 minutes at room temperature, the cells 
were observed using a confocal laser microscope (TCS-SP, 
Leica, Germany) with a 75 mW Ar laser (Annexin-V, 
excitation/detection = 488 nm/500–550 nm; propidium 
iodide, excitation/detection = 488 nm/620–720 nm).
TUNEL method
DNA fragmentations in apoptotic HCT116 cells were detected 
by the TUNEL (terminal deoxynucleotidyl transferase-mediated 
dUTP-biotin nick end labeling) method.10 HCT116 cells were 
seeded at a density of 4.0 × 103 cells in glass bottom dishes in 
a humidified atmosphere of 5% CO2 at 37°C. After 24 hours, 
HL-n were added at the IC50 and the dishes were incubated for 
48 hours. The cells were then fixed with a 4% paraformaldehyde 
solution and stained using an in situ cell death detection 
kit (Roche Diagnostics) according to the manufacturer’s International Journal of Nanomedicine 2011:6
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Figure 1 Time course of dhy change (A) and the size distribution (B) of HL-n. HL-n 
(n = 21, 23, 25) were prepared by sonication of a mixture containing DMPC and C12(EO)n 
using a bath type sonicator in 5% glucose solution. The diameter (dhy) of HL-n was 
measured by a dynamic light scattering method using an electrophoretic light scattering 
spectrophotometer at 25°C. Data are the mean ± standard error of the mean (n = 3) 
from three independent experiments. [DMPC] = 10 mM, [C12(EO)n] = 1.1 mM.
Abbreviations: DMPC, dimyristoylphosphatidylcholine; HL, hybrid liposomes.
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recommendations. The stained cells were observed using 
a confocal laser microscope with an Ar laser (TUNEL, 
excitation/detection = 488 nm/500–550 nm) and a He-Ne laser 
(TOPRO-3, excitation/detection = 633 nm/650–740 nm).
Flow cytometry
Cell cycle analysis of  HCT116 cells was performed with a 
flow cytometer (Epics XL system II, Beckman Coulter, Ful-
lerton, CA).13,16 HCT116 cells were seeded at a density of 
2.0 × 103 cells per well in 6-well plates (Sumitomo Bakelite) 
and incubated in a humidified atmosphere of 5% CO2 at 37°C. 
After 24 hours, HL-n were added into each well and the plates 
were incubated for 48 hours. After treatment with trypsin, the 
cells were centrifuged at 200 × g for 5 minutes, washed with 
phosphate-buffered saline, and resuspended in phosphate-
buffered saline containing 40 µg/mL propidium iodide, 1 mg/
mL RNase, and 0.1% Triton X-100 in a dark room. The 
DNA contents of the cells were then analyzed using a flow 
cytometer with a single excitation 488 nm of 15 mW Ar laser. 
The propidium iodide signal was detected by FL3 sensor at 
605–635 nm and the data were analyzed on WinMDI (v 2.8; 
The Scripps Research Institute, Flow Cytometry Core Facility, 
La Jolia, CA) software.
Enzyme immunometric assay
Expression of p21 WAF1/CIP1 in HCT116 cells was ana-
lyzed by an enzyme immunometric assay.20 HCT116 cells 
were seeded at a density of 2.0 × 103 cells per well in 6-well 
plates and incubated in a humidified atmosphere of 5% CO2 
at 37°C. After 24 hours, HL-23 were added at 200 µM and 
the plates were incubated for 48 hours. After treatment with 
trypsin, the cells were centrifuged at 200 × g for 5 minutes, 
washed with phosphate-buffered saline, and resuspended in 
cell lysis buffer solution containing 50 mM Tris HCl, pH 7.4, 
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 
1% sodium deoxycholate, and 0.1% sodium dodecyl sulfate. 
Then, p21 WAF1/CIP1 in the cell lysates was assayed using 
a TiterZyme® EIA human p21 enzyme immunometric assay 
kit (Assay Designs, Ann Arbor, MI) according to the manu-
facturer’s recommendations.
Results and discussion
The hybrid liposomes were prepared by sonication of a 
mixture containing 90 mol% DMPC and 10 mol% C12(EO)n 
(n = 21, 23, 25) in 5% glucose solutions, and the morphology 
of HL-n was measured by the dynamic light scattering 
method. The results are shown in Figure 1. The diameters 
(dhy) of the HL-n were about 40 nm with a narrow range in the 
size distribution and remained stable for more than 1 month, 
whereas that of liposomes composed of only DMPC were 
about 200 nm in diameter. This suggested that HL-n less than 
100 nm in diameter could avoid clearance by the reticular 
endothelial system in vivo.21
First, we examined the inhibitory effects of HL-n (n = 21, 
23, 25) on the growth of colon cancer HCT116 cells in vitro on 
the basis of WST-1 assay. The number of viable HCT116 cells 
was evaluated in the absence or in the presence of different 
concentrations of HL-n by WST-1, and the IC50 of HL-n 
was determined from the concentration-dependence of the 
viable cell number (Supplementary Figure S1). In Figure 2,   
the IC50 value is the concentration of HL-n necessary to 
inhibit the growth of HCT116 cells by half. The IC50 values 
were 0.190 mM DMPC for HL-21, 0.183 mM DMPC for 
HL-23, and 0.202 mM DMPC for HL-25. On the other hand, 
the IC50 of DMPC liposomes was 0.477 mM and the value International Journal of Nanomedicine 2011:6
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Figure 2 IC50 of HL-n on the growth of HCT116 cells in vitro. Inhibitory effects of 
HL-n (n = 21, 23, 25) on the growth of HCT116 cells were examined on the basis of 
WST-1 assay. Fifty percent inhibitory concentration (IC50) of HL-n was determined 
from the concentration-dependence for the viable cell number of HCT116 cells 
incubated in the presence of HL-n for 48 hours. Data are the mean ± standard error 
of the mean (n = 3) from three independent experiments.
Abbreviations: DMPC, dimyristoylphosphatidylcholine; HL, hybrid liposomes; IC50, 
50 percent inhibitory concentration.
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was more than twice those of HL-n. These results indicate 
that HL-n should be effective for inhibiting the growth of 
HCT116 cells as well as in the case of other colon cancer 
cell lines.16,17 Hybrid liposomes being more fluid as compared 
with DMPC liposomes showed strong inhibitory effects on 
the growth of human colon cancer (WiDr) cells16 and human 
leukemia cells.12 The strong inhibitory effects on the growth 
of HCT116 cells should be closely related to the membrane 
fluidity of HL-n.
Second, we examined the induction of apoptosis by 
HL-n in HCT116 cells with a confocal laser microscope. It 
is well known that the redistribution of phosphatidylserines 
from the inner to outer leaflet of the plasma membrane is a 
hallmark of early apoptotic cells. Therefore, HCT116 cells 
were treated with HL-n for 3 hours and observed by the 
Annexin-V/propidium iodide dual staining method. The 
double staining assay with Annexin-V and propidium 
iodide19,22 detects early apoptotic and necrotic cells as green 
and red fluorescent cells, respectively. The fluorescence 
micrographs of HCT116 cells treated with HL-n are shown 
in Figure 3A. Green fluorescence was observed at the plasma 
membranes of HCT116 cells after treatment with HL-n, 
although no green fluorescence was observed in the case of 
DMPC liposomes. No red fluorescent cells were observed in 
HCT116 cells treated with HL-n, suggesting that HL-n did 
not induce necrosis in HCT116 cells. On the other hand, the 
latter apoptotic cells are characterized by increased plasma 
membrane permeability and fragmentation of nuclear DNA. 
Using the TUNEL method, we observed the DNA fragmen-
tation of HCT116 cells treated with HL-n for 48 hours. 
The fluorescence micrographs are shown in Figure 3B. The 
nuclei of all cells were stained by TOPRO-3 and exhibited 
red fluorescence. As regards TUNEL staining, green or 
orange (overlay) fluorescence was observed in cells treated 
with HL-n, indicating the presence of nuclear condensation 
and fragmentation in apoptotic cells. In contrast, green (or 
orange) fluorescence in HCT116 cells was not observed in the 
case of DMPC liposomes. These observations demonstrated 
induction of apoptotic cell death toward HCT116 cells by 
HL-n. It has been already elucidated that hybrid liposomes 
induce apoptosis in various tumor cells, with activations 
of caspases-3, -8, and -9, and reduction of mitochondria 
membrane potential.8,11–13,16 HL-n could probably fuse and 
accumulate into HCT116 cells, and induce apoptosis through 
activation of caspase cascades.
In order to gain further insight into the mechanism of 
inhibitory effects of HL-n on growth of HCT116 cells, we 
performed a cell cycle analysis of HCT116 cells treated 
with HL-n by flow cytometry. The results are shown in 
Figure 4A. After treatment with HL-n, G0/G1 populations 
of HCT116 cells gradually increased with the decrease of 
S and G2/M populations in the lower concentration range 
([DMPC] = 0–0.2 mM). Interestingly, G0/G1 populations 
of HCT116 cells gradually decreased with the increase 
in sub-G1 populations in the higher concentration range 
([DMPC] = 0.2–0.5 mM). These results indicate that HL-n 
should arrest the cell cycle progression of HCT116 cells at 
the G0/G1 phase at the lower concentrations and induce apop-
tosis of HCT116 cells at the higher concentrations. In regard 
to induction of cell cycle arrest by HL-n, we examined the 
regulatory protein p21 WAF1/CIP1, which play a key role in 
regulating entry of cells at the G1/S transition check point,23 in   
HCT116 cells by an enzyme immunometric assay. As shown 
in Figure 4B, a significant increase in p21 WAF1/CIP1 was 
observed in HCT116 cells at 48 hours after the treatment with 
HL-23 ([DMPC] = 0.2 mM). This result suggests that hybrid 
liposome-mediated G0/G1 arrest of HCT116 cells was asso-
ciated with upregulation of p21 WAF1/CIP1 protein. With 
respect to cell cycle regulation, some studies have reported 
that cell cycle arrest is closely associated with metabolic 
events in plasma membranes.24–27 Although the mechanistic 
details are not yet clear, it seems that HL-n could accumulate 
in plasma membranes of HCT116 cells, change the membrane 
characteristics related to cell cycle progression, and induce 
G0/G1 phase arrest. On the other hand, G0/G1 phase arrest 
was also observed for HCT116 cells treated with DMPC 
liposomes, that is, the G0/G1 population of HCT116 cells 
increased with the decrease in S and G2/M populations in a 
dose-dependent manner. However, the sub-G1 population of 
HCT116 cells was not detected in the whole concentration International Journal of Nanomedicine 2011:6
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Figure 3 Induction of apoptosis in HCT116 cells by HL-n. (A) Fluorescence micrographs of HCT116 cells stained with FLUOS-conjugated Annexin-V and propidium iodide 
after the treatment with HL-n (n = 21, 23, 25) for 3 hours. (B) Fluorescence micrographs of HCT116 cells stained with TUNEL and TOPRO-3 after the treatment with HL-n 
(n = 21, 23, 25) for 48 hours. In both experiments, HCT116 cells were treated with HL-n at the IC50 (DMPC liposomes; [DMPC] = 0.477 mM, HL-21; [DMPC] = 0.190 mM, 
HL-23; [DMPC] = 0.183 mM, HL-25; [DMPC] = 0.202 mM).
Note: Scale bar; 20 µm.
Abbreviations: DMPC, dimyristoylphosphatidylcholine; HL, hybrid liposomes; IC50, 50 percent inhibitory concentration.
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range ([DMPC] = 0–0.5 mM) in this study. These results in 
relation to the cell cycle were in good agreement with the 
observations for apoptotic HCT116 cells by fluorescence 
microscopy. In our previous study, we reported that HL-n 
elicited G1 phase cell cycle arrest of human cholangiocarci-
noma cells, although HL-n did not induce apoptosis toward 
cholangiocarcinoma cells.18 In this study, we have found for 
the first time that inhibitory effects of HL-n on the growth 
of HCT116 cells could be caused by induction of cell cycle 
arrest at the G0/G1 phase along with apoptotic cell death.
As mentioned above, markedly inhibitory effects of HL-n 
on growth of human colon cancer HCT116 cells in vitro 
were obtained in this study. It is noteworthy that induction 
of cell cycle arrest along with apoptosis with HL-n could International Journal of Nanomedicine 2011:6
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Figure 4 Cell cycle analysis of HCT116 cells treated with HL-n. (A) Cell cycle analysis of HCT116 cells was performed by flow cytometry. HCT116 cells were incubated 
in the presence of HL-n (n = 21, 23, 25) at the IC50 for 48 hours. DNA contents in HCT116 were analyzed using a flow cytometer.a (B) Expression of p21 WAF1/CIP1 in 
HCT116 cells treated with HL-23. HCT116 cells were incubated in the presence or absence (control) of HL-23 ([DMPC] = 0.2 mM) for 48 hours and p21 expression was 
determined by enzyme immunometric assay.b (C) Schematic representation of cell cycle arrest and apoptosis in cancer cells induced by HL-n.
Notes: *Significant difference (P , 0.05) compared with the controls (Student’s t-test); adata are the mean ± standard error of the mean (n = 3) from three independent 
experiments; bdata are the mean ± standard error of the mean (n = 6) from two independent experiments.
Abbreviations: DMPC, dimyristoylphosphatidylcholine; HL, hybrid liposomes.
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play an important role in growth inhibition of HCT116 cells 
(Figure 4C). Deviation from the normal cell cycle and the 
resistance to apoptosis lie at the heart of tumor development.28 
This study suggests that HL-n could be an effective chemo-
therapeutic agent for colon cancer in the near future.
Conclusion
In conclusion, we have clearly demonstrated the inhibi-
tory effects of hybrid liposomes composed of DMPC   
and C12(EO)n on growth of human colon cancer HCT116 cells 
in vitro. The noteworthy aspects are as follows. The diameters International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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of the HL-n were less than 100 nm and remained stable for 
more than 1 month. The markedly inhibitory effects of HL-n 
on growth of HCT116 cells were obtained. IC50 values of 
HL-n were less than half of that of DMPC liposomes. The 
inhibitory effects of HL-n on the growth of HCT116 cells 
were attained through induction of cell cycle arrest at G0/G1 
phase along with apoptotic cell death. It is worthy of note 
that HL-n can induce both cell cycle arrest and apoptosis in 
colon cancer cells. The results of this study should contribute 
to novel chemotherapy for colon cancer.
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Figure S1 Inhibitory effects of HL-n on the growth of HCT116 cells for 48 hours.
Abbreviation: DMPC, dimyristoylphosphatidylcholine.
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